PortfoliosLab logoPortfoliosLab logo
ISIN
US92561V1098
CUSIP
92561V109
IPO Date
Sep 4, 2020

Highlights

EPS (TTM)
-$9.07
Gross Profit (TTM)
-$643.00K
EBITDA (TTM)
-$41.22M
Year Range
$0.52 - $13.75
Target Price
$8.75
ROA (TTM)
-334.63%
ROE (TTM)
-1,179.75%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

RBOT Performance Chart

Vicarious Surgical Inc. (RBOT) is down 65.7% since the beginning of the year. At $1 per share, RBOT is trading 94.6% below its 52-week high of $14. Investors who bought $1,000 worth of RBOT shares 5 years ago would now be looking at an investment worth $3.


Loading charts...

S&P 500 Index

Returns By Period

Vicarious Surgical Inc. (RBOT) has returned -65.67% so far this year and -90.11% over the past 12 months.


Vicarious Surgical Inc.

1D
-8.02%
1M
-17.13%
YTD
-65.67%
6M
-71.35%
1Y
-90.11%
3Y*
-77.57%
5Y*
-69.81%
10Y*

Benchmark (S&P 500 Index)

1D
0.39%
1M
5.25%
YTD
9.81%
6M
11.11%
1Y
28.72%
3Y*
21.12%
5Y*
12.46%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RBOT Monthly Returns History

Historically, 34% of months were positive and 66% were negative. The best month was Nov 2024 with a return of +76.9%, while the worst month was Mar 2026 at -55.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 9 months.

On a daily basis, RBOT closed higher 42% of trading days. The best single day was Feb 27, 2024 with a return of +57.1%, while the worst single day was Mar 4, 2026 at -53.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20261.38%-7.27%-55.93%0.11%-17.22%-65.67%
20251.37%-17.54%-40.36%25.91%-8.72%-0.53%18.13%-31.04%-9.82%-3.27%-43.53%-27.91%-83.51%
20249.74%5.47%-28.96%-6.93%12.30%-37.90%22.49%-12.24%-9.98%39.26%76.86%-5.93%19.63%
202334.16%3.32%-18.93%-0.88%-6.67%-12.86%-10.38%-43.62%-36.11%-30.17%-33.41%33.49%-81.85%
2022-39.45%-4.04%-17.99%-2.77%-10.98%-32.88%32.65%-4.36%-10.19%15.52%-9.56%-42.29%-80.98%
2021-0.00%0.89%-3.02%-0.10%-0.40%0.81%-0.50%0.60%49.90%-12.63%0.23%-18.93%4.53%

Return for Risk

Risk / Return Rank

RBOT ranks 14 for risk / return — in the bottom 14% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


RBOT Risk / Return Rank: 1414
Overall Rank
RBOT Sharpe Ratio Rank: 88
Sharpe Ratio Rank
RBOT Sortino Ratio Rank: 1111
Sortino Ratio Rank
RBOT Omega Ratio Rank: 22
Omega Ratio Rank
RBOT Calmar Ratio Rank: 2424
Calmar Ratio Rank
RBOT Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Vicarious Surgical Inc. (RBOT) and compare them to S&P 500 Index.


RBOTBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.82

2.43

-3.25

Sortino ratio

Return per unit of downside risk

-1.02

4.24

-5.26

Omega ratio

Gain probability vs. loss probability

0.72

2.20

-1.48

Calmar ratio

Return relative to maximum drawdown

-0.49

3.28

-3.77

Martin ratio

Return relative to average drawdown

-0.74

13.68

-14.42

Dividends

Dividend History


Vicarious Surgical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Vicarious Surgical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vicarious Surgical Inc. was 99.83%, occurring on Jun 2, 2026. The portfolio has not yet recovered.

The current Vicarious Surgical Inc. drawdown is 99.83%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-99.83%Jun 2026
4y 8mo
4y 8moOct 2021 - now
2021 pullback2021
-9.50%Sep 2021
6mo 25d1d
6mo 26dFeb 2021 - Sep 2021
2021 pullback2021
-7.84%Sep 2021
1d2d
3dSep 2021 - Sep 2021
2021 pullback2021
-4.54%Sep 2021
1d1d
2dSep 2021 - Sep 2021
2020 pullback2020
-2.53%Oct 2020
4d2mo 3d
2mo 7dOct 2020 - Dec 2020

Drawdown Indicators


RBOTBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.83%

-56.24%

-43.59%

Max Drawdown (1Y)

Largest decline over 1 year

-94.35%

-8.58%

-85.77%

Max Drawdown (3Y)

Largest decline over 3 years

-98.92%

-17.02%

-81.90%

Max Drawdown (5Y)

Largest decline over 5 years

-99.83%

-24.82%

-75.01%

Max Drawdown (10Y)

Largest decline over 10 years

-31.81%

Current Drawdown

Current decline from peak

-99.83%

0.00%

-99.83%

Average Drawdown

Average peak-to-trough decline

-69.74%

-10.46%

-59.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

31.18%

2.11%

+29.07%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Vicarious Surgical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Vicarious Surgical Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with RBOT

Add Vicarious Surgical Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with RBOT